FOUND: Abbvie s quarterly earnings preview what you need to know - You Need To See This

North Chicago, Illinois-based AbbVie Inc. (ABBV) focuses on creating medicines and solutions that address complex health issues and enhance people's lives through its core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and more. With a market cap of $310.2 billion, AbbVie operates as one of the largest biopharmaceutical companies in the world.

The pharma giant is gearing up to announce its fourth-quarter results before the market opens on Friday, Jan. 31. Ahead of the event, analysts expect AbbVie to report a non-GAAP profit of $2.10 per share, down 24.7% from $2.79 per share reported in the year-ago quarter. The company has a robust earnings surprise history. It has surpassed Wall Street’s bottom-line estimates in each of the past four quarters. Its adjusted EPS for the last reported quarter grew 1.7% year-over-year to $3.00, exceeding analysts’ estimates by 2.7%.